Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alpha-chymotrypsin is a serine protease enzyme produced in the pancreas as an inactive precursor (chymotrypsinogen) and activated in the duodenum by trypsin cleavage. It catalyzes the hydrolysis of peptide bonds on the carboxyl side of large hydrophobic amino acids such as phenylalanine, tryptophan, and tyrosine, playing a critical role in protein digestion. Structurally, it is characterized by three peptide chains held together by disulfide bonds and a catalytic triad (serine, histidine, aspartate) that orchestrates nucleophilic attack on peptide substrates. Besides its digestive role, alpha-chymotrypsin is used therapeutically as an anti-inflammatory and proteolytic agent in surgery, particularly ophthalmic procedures. Loss of enzyme activity can occur due to denaturation from heat or pH changes, and allergic or irritant reactions may rarely limit its clinical use[1][2][3][4][5][7].
Proteolytic cleavage of peptide bonds C-terminal to aromatic amino acids (tyrosine, tryptophan, phenylalanine) in proteins and polypeptides, via a covalent hydrolysis (ping-pong) mechanism involving a catalytic triad (Ser195, His57, Asp102)[1][2][3][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-chymotrypsin (α-Chymotrypsin).